Manufacturer
Liquidia Technologies
- Products listed
- 4
- Molecules
- 1
- Therapy areas
- 1
Liquidia Technologies is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 4 of its products across 1 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- Liquidia Technologies, Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Liquidia Technologies products through licensed channels, with the documents your regulator needs.
Haematology
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Yutrepia 106 mcg inhalation capsuleInhalation | Treprostinil | US FDA | Available on request |
| Yutrepia 26.5 mcg inhalation capsuleInhalation | Treprostinil | US FDA | Available on request |
| Yutrepia 53 mcg inhalation capsuleInhalation | Treprostinil | US FDA | Available on request |
| Yutrepia 79.5 mcg inhalation capsuleInhalation | Treprostinil | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Liquidia Technologies
Send a request for any of these products. We confirm the licensed source, documents and lead time.